Overview

A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to provide additional efficacy and safety data for a treatment strategy based on the combination valsartan with amlodipine in hypertensive patients previously treated with monotherapy and remaining uncontrolled. A naturalistic approach will be taken comparing two different doses, i.e. 160mg of valsartan with amlodipine 5mg and 10mg with possible addition of HCTZ
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Hydrochlorothiazide
Valsartan